German Remedies, a part of the Zydus Group, has launched Fludara Oral (Fludarabine) for the treatment of Chronic Lymphocytic Leukaemia. According to a release issued by Cadila Healthcare to the BSE, the drug is a product of Berlex, a U.S. affiliate of Schering AG Germany.J C Jani executive director of Zydus Cadila, and Head of German Remedies stated that, "We have been introducing several new therapies that can improve the quality of life for the patients and enable better disease management. With Oncology being one of our core therapy areas, this new addition further strengths our product portfolio of critical-care therapies which includes cytostatics."
